Performance of T2Bacteria in Relationship to Blood Cultures - a Retrospective Comparative Study

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2024 Aug 3

PMID 39096321

Authors

David Yu

Anna Ekwall-Larson

Volkan Ozenci

Affiliations

Soon will be listed here.

Abstract

Purpose: Blood culture (BC) is the gold standard for diagnosing blood stream infections (BSI) but is limited by long turnaround times (TAT) and low detection rate. The T2 Magnetic Resonance method (T2MR) offers a rapid, culture-independent alternative. The objective of this study was to compare the performance of the T2Bacteria assay to BCs in a real-world setting.

Methods: Retrospective comparative study consisting of T2Bacteria samples and BCs sampled within 72 h from the T2Bacteria sample. The primary outcome was detections by BC and T2Bacteria, respectively. The secondary outcome was difference in TAT.

Results: In total, 640 episodes were included, consisting of 640 T2Bacteria samples and 2,117 BCs. A median of three BCs was collected for each T2Bacteria sample. Overall positivity was 101 (15.8%) by either method. In 29 (28.7%) episodes, both T2Bacteria and BC were concordantly positive. In discordant episodes, 46/101 (45.5%) episodes were T2Bacteria positive/BC negative and 26/101 (25.7%) were T2Bacteria negative/BC positive (McNemar χ, p < 0,05). In T2Bacteria positive/BC negative episodes, eight had growth of the same microorganism in a non-BC culture. Median (IQR) TAT for BC was 35 h and 30 min (25 h 50 min - 45 h 24 min), compared to 21 h and 3 min (17 h 6 min - 27 h 30 m) for T2Bacteria (p < 0.001), with longer delays for samplings occurring outside work hours.

Conclusions: The study highlights a high discordance between T2Bacteria and BC and suggests complementary roles of the methods in BSI diagnostics. Furthermore, it is crucial to improve TAT by reducing preanalytical delays.

References

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith C, French C . Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021; 47(11):1181-1247. PMC: 8486643. DOI: 10.1007/s00134-021-06506-y. View

Lamy B, Dargere S, Arendrup M, Parienti J, Tattevin P . How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art. Front Microbiol. 2016; 7:697. PMC: 4863885. DOI: 10.3389/fmicb.2016.00697. View

Banerjee R, Ozenci V, Patel R . Individualized Approaches Are Needed for Optimized Blood Cultures. Clin Infect Dis. 2016; 63(10):1332-1339. PMC: 5091349. DOI: 10.1093/cid/ciw573. View

Yu D, Unger D, Unge C, Parke A, Sunden-Cullberg J, Stralin K . Correlation of clinical sepsis definitions with microbiological characteristics in patients admitted through a sepsis alert system; a prospective cohort study. Ann Clin Microbiol Antimicrob. 2022; 21(1):7. PMC: 8864844. DOI: 10.1186/s12941-022-00498-3. View

Peri A, Harris P, Paterson D . Culture-independent detection systems for bloodstream infection. Clin Microbiol Infect. 2021; 28(2):195-201. DOI: 10.1016/j.cmi.2021.09.039. View

Tassinari M, Zannoli S, Farabegoli P, Pedna M, Pierro A, Mastroianni A . Rapid diagnosis of bloodstream infections in the critically ill: Evaluation of the broad-range PCR/ESI-MS technology. PLoS One. 2018; 13(5):e0197436. PMC: 5953471. DOI: 10.1371/journal.pone.0197436. View

Opota O, Jaton K, Greub G . Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from blood. Clin Microbiol Infect. 2015; 21(4):323-31. DOI: 10.1016/j.cmi.2015.02.005. View

Nguyen M, Clancy C, Pasculle A, Pappas P, Alangaden G, Pankey G . Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study. Ann Intern Med. 2019; 170(12):845-852. DOI: 10.7326/M18-2772. View

Clancy C, Nguyen M . T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward. J Antimicrob Chemother. 2018; 73(suppl_4):iv2-iv5. DOI: 10.1093/jac/dky050. View

10.

De Angelis G, Posteraro B, De Carolis E, Menchinelli G, Franceschi F, Tumbarello M . T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood. J Antimicrob Chemother. 2018; 73(suppl_4):iv20-iv26. DOI: 10.1093/jac/dky049. View

11.

Voigt C, Silbert S, Widen R, Marturano J, Lowery T, Ashcraft D . The T2Bacteria Assay Is a Sensitive and Rapid Detector of Bacteremia That Can Be Initiated in the Emergency Department and Has Potential to Favorably Influence Subsequent Therapy. J Emerg Med. 2020; 58(5):785-796. DOI: 10.1016/j.jemermed.2019.11.028. View

12.

Quirino A, Scaglione V, Marascio N, Mazzitelli M, Garofalo E, Divenuto F . Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience. BMC Infect Dis. 2022; 22(1):113. PMC: 8805379. DOI: 10.1186/s12879-022-07096-w. View

13.

Metzgar D, Frinder M, Rothman R, Peterson S, Carroll K, Zhang S . The IRIDICA BAC BSI Assay: Rapid, Sensitive and Culture-Independent Identification of Bacteria and Candida in Blood. PLoS One. 2016; 11(7):e0158186. PMC: 4934770. DOI: 10.1371/journal.pone.0158186. View

14.

Jordana-Lluch E, Rivaya B, Marco C, Gimenez M, Quesada M, Escobedo A . Molecular diagnosis of bloodstream infections in onco-haematology patients with PCR/ESI-MS technology. J Infect. 2016; 74(2):187-194. DOI: 10.1016/j.jinf.2016.11.011. View

15.

Ekwall-Larson A, Yu D, Dinnetz P, Nordqvist H, Ozenci V . Single-Site Sampling versus Multisite Sampling for Blood Cultures: a Retrospective Clinical Study. J Clin Microbiol. 2021; 60(2):e0193521. PMC: 8849186. DOI: 10.1128/JCM.01935-21. View

16.

Fukushima S, Hagiya H, Fujita K, Kamiyama S, Yamada H, Kishida M . Clinical and microbiological characteristics of polymicrobial bacteremia: a retrospective, multicenter study. Infection. 2022; 50(5):1233-1242. DOI: 10.1007/s15010-022-01799-7. View

17.

Kalligeros M, Zacharioudakis I, Tansarli G, Tori K, Shehadeh F, Mylonakis E . In-depth analysis of T2Bacteria positive results in patients with concurrent negative blood culture: a case series. BMC Infect Dis. 2020; 20(1):326. PMC: 7206677. DOI: 10.1186/s12879-020-05049-9. View